[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f--1e6fUCTd8ybp5s9P_r5Q20HacziWzQ_fzBTald2b8":8,"$fng5AxjeQ6t9VGD1X071Ik6TR6zONG_o8IyQj9Lk8ioE":55,"$fn8i9Mo8gtK-JDW0lpzHN_ZFHg7-m-pKEoscVAgOwhco":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75472,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"乳腺癌早期靶向药物与化疗用药指南","","https://ystcdn.venuertc.com/venue/AI/bae02b19-e338-47e1-8f17-3fbfc9d4e71a.jpg","\u003Cdiv id=\"material_title\">\n  \u003Ch1 class=\"drugguide_title\">乳腺癌早期靶向药物与化疗用药指南\u003C/h1>\n  \u003Cp class=\"drugguide_introduction\">说到乳腺癌早期治疗，很多人会好奇，术后都用些什么药？其实，药物包括化疗药和靶向药，各自作用不一样。今天我们就用一篇长文，帮大家系统梳理乳腺癌术后早期阶段涉及的药品：成分特点、用法、注意事项、不良反应、储存要求等7大细节。希望可以让读者一看就明白，安全规范用药要掌握哪些关键点。👩‍⚕️\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg1\">\n  \u003Ch2 class=\"drugguide_subtitle\">01 化疗药物：多西他赛（Docetaxel）与环磷酰胺的作用机制\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛是一类紫杉醇类药物，主要通过抑制微管蛋白促使肿瘤细胞停止分裂，从而发挥杀伤作用。\u003C/li>\n    \u003Cli>环磷酰胺属于烷化剂，通过在细胞DNA上加成，干扰遗传物质复制，导致肿瘤细胞死亡。\u003C/li>\n    \u003Cli>靶向药（如注射型曲妥珠单抗，Trastuzumab）依靠识别HER2蛋白靶点阻断癌细胞信号传导，抑制细胞增殖。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">🔬💉\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg2\">\n  \u003Ch2 class=\"drugguide_subtitle\">02 化疗及靶向药的剂型与给药形式\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛与环磷酰胺常见为注射剂型，通过静脉滴注方式给药。标准操作下需由专业医护操作，不能自行注射。\u003C/li>\n    \u003Cli>曲妥珠单抗目前临床主要为静脉注射型，部分地区可选皮下注射型，规格以mg计量。\u003C/li>\n    \u003Cli>不同批次药品包装和规格可能略有差异，用药前务必核查药品标签和外观。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">💧🩺\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg3\">\n  \u003Ch2 class=\"drugguide_subtitle\">03 用药时间、方法与给药周期\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛和环磷酰胺联合方案，通常每3周为1周期，具体数量根据临床方案制定。\u003C/li>\n    \u003Cli>每次静脉滴注须在专科病房完成，过程约需60-120分钟。患者需提前检查血常规、肝肾功能。\u003C/li>\n    \u003Cli>靶向药曲妥珠单抗，首剂启动剂量与后续维持剂量不同，后续每3周一次维持给药。\u003C/li>\n    \u003Cli>正确做法：始终遵循医师和药师设定的方案，按时到院复查、签字确认药品种及批次。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">⏰🔄\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg4\">\n  \u003Ch2 class=\"drugguide_subtitle\">04 药品相互作用需要警惕哪些？\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛与环磷酰胺均可与其他抗癌药物协同，也有与某些药品产生拮抗或增强风险（如苯妥英、华法林等需格外注意）。\u003C/li>\n    \u003Cli>曲妥珠单抗与蒽环类药物联用时会增加心脏毒性风险，建议按方案分阶段使用，绝不可自行组合药物。\u003C/li>\n    \u003Cli>部分中药成分或保健品如人参、黄芪也可能改变血药浓度，建议用药期间停用所有草药。\u003C/li>\n    \u003Cli>正确做法：主动告知医生最近使用的所有药品（处方和非处方），包括营养品，以避免危险相互作用。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">⚠️🥼\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg5\">\n  \u003Ch2 class=\"drugguide_subtitle\">05 特殊人群（老年/肝肾功能障碍）用药调整\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>老年患者（如本案71岁女性）肝、肾代谢功能相对减弱，需根据功能评分调整给药剂量，减少不良反应。\u003C/li>\n    \u003Cli>肝功能受损者用多西他赛要慎重，一旦谷丙转氨酶或胆红素升高，须调整或暂停治疗。\u003C/li>\n    \u003Cli>肾功能不全时环磷酰胺剂量也需下调。\u003C/li>\n    \u003Cli>妊娠或哺乳期妇女禁止使用这些药物，不论是哪一种。\u003C/li>\n    \u003Cli>肝肾异常或老年患者要加密检测血常规及肝肾指标，每个疗程前均要检查。\u003C/li>\n    \u003Cli>正确做法：特殊人群用药前，必须系统评估个体生理指标，不可套用标准剂量。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">👵🔬\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg6\">\n  \u003Ch2 class=\"drugguide_subtitle\">06 常见不良反应与处理\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛常见不良反应：脱发（＞80%）、口腔炎、白细胞减少。严重时可能引发感染或过敏反应。\u003Cbr>应对措施：白细胞下降需规范使用升白药，口腔炎可用口腔漱口液，脱发无需特殊处理。\u003C/li>\n    \u003Cli>环磷酰胺常见：恶心、呕吐、膀胱炎、不孕（长期大剂量）。可用止吐药辅助，饮水充足以减少膀胱炎。\u003C/li>\n    \u003Cli>曲妥珠单抗最需警惕心肌损伤。数据显示心脏毒性发生率约3-5%（Slamon et al., 2001），用药前后需心脏彩超监测。\u003C/li>\n    \u003Cli>出现过敏反应、严重发热或心慌，应立即停止用药并就诊。\u003C/li>\n    \u003Cli>正确做法：建立个人用药不良反应登记本，每次治疗后自查体感异常，并主动与医生沟通。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">🚑⚕️\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg7\">\n  \u003Ch2 class=\"drugguide_subtitle\">07 药品储存条件及过期处理方法\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>多西他赛注射液需在2-8°C冰箱冷藏保存，避免日晒和高温。环磷酰胺原瓶密闭，干燥处保存。\u003C/li>\n    \u003Cli>曲妥珠单抗保存需低温冷藏，只能专业药房配发。家庭不能存储剩余药品。\u003C/li>\n    \u003Cli>过期药品不能使用，也不可丢进下水道，应送到专业药房或医院指定回收点。\u003C/li>\n    \u003Cli>正确做法：家中存储药品前一定查验有效期标识，每次用药前先看外观，若变色或沉淀须报废。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">🧊📦\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg8\">\n  \u003Ch2 class=\"drugguide_subtitle\">08 漏服与过量的补救措施\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>化疗药物与靶向药均为专业机构定点使用，患者不可自行操作。\u003C/li>\n    \u003Cli>任何一次漏服或提前中止疗程，需立即联系主治医生重新制定方案。\u003C/li>\n    \u003Cli>误服或过量用药（如剂量出错或重复注射），不能自行处理，应立刻就医，必要时启动急救程序。\u003C/li>\n    \u003Cli>正确做法：绝不自行调整任何剂量，疗程安排由专业人员统一负责，对用药时的每一次异常详细记录。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">📖🚨\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg9\">\n  \u003Ch2 class=\"drugguide_subtitle\">09 用药案例分享\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>一位71岁女性，术后指示使用多西他赛和环磷酰胺联合方案，期间按时复查及监测，未见严重不良反应，为后续靶向药物应用铺平基础。\u003C/li>\n    \u003Cli>临床应用注射型曲妥珠单抗过程中，起始剂量严格参照说明书，心脏功能周期评估，患者顺利完成首次靶向治疗。\u003C/li>\n    \u003Cli>历史数据表明，规范周期化疗与靶向药联合应用能显著提升用药安全，即使患者高龄，只要按流程执行，风险可控。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">👩‍🌾🏥\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_section drugguide_bg10\">\n  \u003Ch2 class=\"drugguide_subtitle\">10 结语与安全用药建议\u003C/h2>\n  \u003Cul class=\"drugguide_list\">\n    \u003Cli>无论是化疗药（多西他赛、环磷酰胺）还是靶向药（曲妥珠单抗），都必须在医生指导下使用，严格遵循剂型、周期、剂量标准。\u003C/li>\n    \u003Cli>药品保存、相互作用、特殊人群剂量调整和不良反应监测都需逐项做到。\u003C/li>\n    \u003Cli>如有身体异常、用药中断、错误用量或发现家庭成员误触药品，第一时间就诊，并妥善处理剩余药品。\u003C/li>\n    \u003Cli>安全用药的底线是：信息透明、过程可控，所有操作都有专业流程支撑。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drugguide_emoji\">🔒💊\u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drugguide_references\">\n  \u003Ch3 class=\"drugguide_reference_title\">参考文献\u003C/h3>\n  \u003Col>\n    \u003Cli>Slamon, D.J., Leyland-Jones, B., Shak, S., et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. \u003Cem>New England Journal of Medicine\u003C/em>, 344(11), 783-792. https://doi.org/10.1056/NEJM200103153441101\u003C/li>\n    \u003Cli>Fumoleau, P., Dose, J.D., Delozier, T., et al. (1996). Phase II trial of docetaxel and cyclophosphamide as combination chemotherapy for women with advanced breast cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>, 14(7), 2036-2041. https://doi.org/10.1200/JCO.1996.14.7.2036\u003C/li>\n    \u003Cli>Swain, S.M., Baselga, J., Kim, S.B., et al. (2015). Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 372(8), 724-734. https://doi.org/10.1056/NEJMoa1413513\u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide_title {\n  font-size: 36px;\n  text-align: center;\n  font-weight: 700;\n  margin-top: 24px;\n  margin-bottom: 18px;\n  color: #2d3a4c;\n  letter-spacing: 2px;\n}\n.drugguide_introduction {\n  font-size: 18px;\n  color: #444a58;\n  text-align: center;\n  margin-bottom: 38px;\n  line-height: 1.6;\n  padding-bottom: 8px;\n  border-bottom: 1px solid #eaeaea;\n}\n.drugguide_section {\n  margin: 38px 22px 38px 22px;\n  border-radius: 18px;\n  box-shadow: 0 4px 16px #e9ecef;\n  padding: 32px 28px 28px 28px;\n  position: relative;\n  background-repeat: no-repeat;\n  background-size: cover;\n  min-height: 140px;\n}\n.drugguide_subtitle {\n  font-size: 26px;\n  font-weight: 600;\n  margin-bottom: 18px;\n  margin-top: 0;\n  color: #39405d;\n  letter-spacing: 1px;\n}\n.drugguide_list {\n  font-size: 19px;\n  color: #313846;\n  line-height: 1.9;\n  padding-left: 18px;\n  margin-bottom: 4px;\n}\n.drugguide_emoji {\n  font-size: 32px;\n  position: absolute;\n  right: 24px;\n  bottom: 18px;\n  opacity: 0.18;\n}\n.drugguide_bg1 {\n  background: linear-gradient(90deg, #e6eefc 0%, #ece8fd 100%);\n}\n.drugguide_bg2 {\n  background: linear-gradient(90deg, #f3fafa 0%, #e5f0ed 100%);\n}\n.drugguide_bg3 {\n  background: linear-gradient(90deg, #fffbe6 0%, #eef1e6 100%);\n}\n.drugguide_bg4 {\n  background: linear-gradient(90deg, #f7eeff 0%, #f3fafa 100%);\n}\n.drugguide_bg5 {\n  background: linear-gradient(90deg, #fff6ea 0%, #eaf6fc 100%);\n}\n.drugguide_bg6 {\n  background: linear-gradient(90deg, #eafafe 0%, #ece8fd 100%);\n}\n.drugguide_bg7 {\n  background: linear-gradient(90deg, #f8f7fa 0%, #f6ffed 100%);\n}\n.drugguide_bg8 {\n  background: linear-gradient(90deg, #eaf6fc 0%, #fffbe6 100%);\n}\n.drugguide_bg9 {\n  background: linear-gradient(90deg, #f3fafc 0%, #ece8fd 100%);\n}\n.drugguide_bg10 {\n  background: linear-gradient(90deg, #f2f5fa 0%, #edf7f1 100%);\n}\n.drugguide_reference_title {\n  font-size: 24px;\n  font-weight: 600;\n  letter-spacing: 1px;\n  margin-top: 28px;\n  margin-bottom: 14px;\n  color: #4d5470;\n  border-bottom: 2px solid #e9ecef;\n  padding-bottom: 4px;\n}\n.drugguide_references {\n  margin: 32px 28px 64px 28px;\n  background: linear-gradient(90deg, #eafafe 0%, #ecf0f3 100%);\n  border-radius: 14px;\n  box-shadow: 0 2px 8px #e9ecef;\n  padding: 20px 24px;\n}\n.drugguide_references ol {\n  font-size: 18px;\n  color: #345062;\n  line-height: 1.8;\n  padding-left: 24px;\n}\n\u003C/style>","\u003Cdiv id=\"material_title\">\n  \u003Ch1 class=\"drugguide_title\">乳腺癌早期靶向药物与化疗用药指南\u003C/h1>\n  \u003Cp class=\"drugguide_",254,"2025-12-06 00:00:32","乳腺癌, 化疗药物, 靶向药物, 多西他赛, 环磷酰胺, 曲妥珠单抗, 安全用药, 不良反应, 药品相互作用","了解乳腺癌早期治疗所需化疗药物与靶向药物的关键知识，包括用法、药物相互作用和不良反应，帮助患者安全用药并提高疗效。","2025-12-15 15:12:14",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]